Ivan Koychev
PhD MRCPsych
Senior Clinical Researcher
- Clinician Scientist Dementias Platform UK
- Consultant Neuropsychiatrist Oxford University Hospitals NHS Foundation Trust
I am a clinical academic psychiatrist (on the GMC Specialist Register for Old Age and General Adult Psychiatry) with a focus on the development of treatments for neuropsychiatric disorders. My research spans the key components of neuroscience clinical trial methodology: conduct of proof-of-concept (PoC) biomarker-based clinical trials in surrogate populations, testing of repurposed compounds, development of stratification and efficacy biomarkers and creation of infrastructure for large-scale stratified recruitment into neuroscience experimental medicine studies and clinical trials. Clinically, I focus on the assessment and management of patients with neuropsychiatric presentations in acute medical settings.
Recent publications
-
Differential association of cerebral blood flow and anisocytosis in APOE ε4 carriers at midlife.
Journal article
Dounavi M-E. et al, (2023), J Cereb Blood Flow Metab
-
Insulin resistance, age and depression’s impact on cognition in middle-aged adults from the PREVENT cohort
Journal article
Bauermeister SD. et al, (2023), BMJ Mental Health, 26, e300665 - e300665
-
Insulin Resistance's Impact on Cognition in Middle Aged Adults from the PREVENT cohort: Interactive Effects with Depression
Preprint
Bauermeister S. et al, (2023)
-
Neurodegenerative disease of the brain: a survey of interdisciplinary approaches
Journal article
Davenport F. et al, (2023), Journal of the Royal Society, Interface, 20
-
Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study.
Journal article
Low A. et al, (2022), Alzheimers Res Ther, 14